Replies to post #3453 on Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

From the article at SA:

Additionally, the Jefferies Group also reiterated an underperform rating for Halozyme with a price target of $5 up from previous $4.5 target, further bringing down the share price. The seven analysts covering the stock now have a consensus price target of $11.25, an almost 19.7% upside, and a consensus rating of Hold.